Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depression: Overview01:18

Depression: Overview

301
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
301
Overview of Cell Death01:30

Overview of Cell Death

7.4K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
7.4K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

6.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

6.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.7K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

147
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
147
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

XPO6 mRNA as a Potential Biomarker for Major Depressive Disorder: Associations with Disease State and Treatment Response.

Neuropsychobiology·2026
Same author

The study of distribution of ingested terbinafine on skin with ambient ionization tandem mass spectrometry.

Journal of food and drug analysis·2024
Same author

Rapid detection of ingested acetaminophen on face mask by ambient ionization tandem mass spectrometry.

Analytica chimica acta·2024
Same author

Orexin/hypocretin and major psychiatric disorders.

Advances in clinical chemistry·2022
Same author

Corrigendum: Isobaric Tags for Relative and Absolute Quantitation Identification of Blood Proteins Relevant to Paroxetine Response in Patients With Major Depressive Disorder.

Frontiers in psychiatry·2022
Same author

Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia: A Systematic Review and Network Meta-analysis.

JAMA psychiatry·2022

Related Experiment Video

Updated: Jul 31, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.4K

Association between programmed death-1 pathway and major depression.

Kuan-Wei Huang1, Tiao-Lai Huang1,2

  • 1Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
|May 4, 2023
PubMed
Summary
This summary is machine-generated.

Major depression (MD) is linked to the immune system. This study found higher PD-L2 levels and lower PD-1 levels in MD patients, suggesting the PD-1 pathway

Keywords:
Immune checkpointPD-1PD-L1PD-L2major depression

More Related Videos

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.6K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

22.3K

Related Experiment Videos

Last Updated: Jul 31, 2025

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

2.4K
An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
06:55

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents

Published on: December 2, 2015

22.6K
A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice
05:28

A Chronic Immobilization Stress Protocol for Inducing Depression-Like Behavior in Mice

Published on: May 15, 2019

22.3K

Area of Science:

  • Immunology
  • Neuroscience
  • Psychiatry

Background:

  • Major depression (MD) is potentially linked to inflammation and immune system dysregulation.
  • The programmed death-1 (PD-1) pathway, including PD-1, PD-L1, and PD-L2, comprises inhibitory immune mediators.
  • Limited research exists on the association between MD and the PD-1 pathway.

Purpose of the Study:

  • To investigate the association between the PD-1 pathway and major depression.
  • To explore the role of PD-1, PD-L1, and PD-L2 in patients diagnosed with MD.

Main Methods:

  • Recruited 54 MD patients and 38 healthy controls over two years.
  • Diagnosed MD using DSM-5 criteria and assessed severity with the 17-item Hamilton Depression Rating Scale (HAM-D).
  • Measured PD-1, PD-L1, and PD-L2 levels in peripheral blood of MD patients after 4 weeks of antidepressant treatment.

Main Results:

  • Significantly elevated PD-L2 levels were observed in MD patients compared to healthy controls.
  • Lower PD-1 levels were found in MD patients after adjusting for age and BMI.
  • A moderate positive correlation was identified between HAM-D scores and PD-L2 levels.

Conclusions:

  • The PD-1 pathway may play a significant role in the pathophysiology of major depression.
  • Further large-scale studies are warranted to validate these findings.